Immutep Limited announced that Lis Boyce has been appointed as Non-Executive Director. She replaces Lucy Turnbull who re-joined the board after the sudden and untimely death of Grant Chamberlain in January 2022. Ms Boyce is a highly experienced corporate lawyer.

She is currently a partner at Piper Alderman and was previously a partner at Dentons, having been at DibbsBarker for nearly 30 years. She has extensive involvement in the Life Sciences and Healthcare sectors and is currently deputy chair of AusBiotech's AusMedtech Advisory Group and a member of AusBiotech's NSW Leadership Committee.